ITDR MS-CETSA was conducted on lumefantrine-treated live parasites and lysate of P. falciparum trophozoites in order to identify potential drug protein targets.
ITDR MS-CETSA was conducted on piperaquine-treated live parasites and lysate of P. falciparum trophozoites in order to identify potential drug protein targets.
ITDR MS-CETSA was conducted on MK4815-treated live parasites and lysate of P. falciparum trophozoites in order to identify potential drug protein targets.
ITDR MS-CETSA was conducted on chloroquine-treated live parasites and lysate of P. falciparum trophozoites in order to identify potential drug protein targets.
ITDR MS-CETSA was conducted on MMV000848-treated live parasites and lysate of P. falciparum trophozoites in order to identify potential drug protein targets.
ITDR MS-CETSA was conducted on amodiaquine-treated live parasites and lysate of P. falciparum trophozoites in order to identify potential drug protein targets.
ITDR MS-CETSA was conducted on MMV665806-treated live parasites and lysate of P. falciparum trophozoites in order to identify potential drug protein targets.
ITDR MS-CETSA was conducted on pyronaridine-treated live parasites and lysate of P. falciparum trophozoites in order to identify potential drug protein targets.
IMPRINTS-CETSA data acquisition of Kasumi-1 cells treated with Vehicle (DMSO), Venetoclax, Decitabine, Azacitidine and Azacitidine+Venetoclax using TMT 16 plex.
IMPRINTS-CETSA data acquisition of Kasumi-1 cells treated with Vehicle (DMSO), Venetoclax, Decitabine, Azacitidine and Azacitidine+Venetoclax using TMT 16 plex.
